SCOAP Program Documents
Additional Program Documents
Washington State’s approach to variability in surgical processes/Outcomes: Surgical Clinical Outcomes Assessment Program (SCOAP) Surgery 2005;138:821-8. View article (PDF).
Negative Appendectomy and Imaging Accuracy in the Washington State Surgical Care and Outcomes Assessment Program; Annals of Surgery (October 2008;248(4):557-63. View article (PDF).
The Agency for Healthcare Research and Quality (AHRQ) has published a free guide entitled, "Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement." Featuring quality improvement initiatives undertaken at the University of California, San Diego Medical Center and Emory University Hospitals, this guide assists quality improvement practitioners in leading an effort to improve prevention of one of the most important problems facing hospitalized patients, hospital-acquired venous thromboembolism.
Protocols
References
- This website contains multiple evidence-based tools called the VTE Safety Toolkit, for the prevention, diagnosis, and treatment of venous thromboembolism (VTE).
The development and implementation of the toolkit was funded by the Agency for Healthcare Research and Quality (AHRQ) for the purpose of increasing the implementation of safe practice interventions for patients at risk for or who are diagnosed with VTE, through use of an evidenced-based and system-supported interactive VTE Safety Toolkit.
- Strategies to Reduce Cardiac Risk in Noncardiac Surgery: Where Are We in 2005?
Anesthesiology. 102(5):881-882, May 2005.
Lee A. Fleisher, M.D.
Links: HTML | PDF (144 K)
- ß-Blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery
Coronary Artery Disease 2007, 18:67–72.
Peter G. Noordzij, Don Poldermans, Olaf Schouten, Frodo Schreiner, Harm H.H. Feringa, Martin Dunkelgrun, Miklos D. Kertai and Eric Boersma
Links: PDF (posted with permission)
- The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers
JAMA, Mar 1990; 263: 1653 - 1657.
B. M. Psaty, T. D. Koepsell, E. H. Wagner, J. P. LoGerfo and T. S. Inui
Department of Medicine, University of Washington, Seattle.
Link: Abstract
- ß-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Clinical Applications
JAMA, Mar 2002; 287: 1445 - 1447.
Andrew D. Auerbach, MD, MPH; Lee Goldman, MD
Links: Abstract | HTML | PDF
- Increase of 1-year Mortality After Perioperative Beta-blocker Withdrawal in Endovascular and Vascular Surgery Patients
European Journal of Vascular and Endovascular Surgery
Volume 33, Issue 1 , January 2007, Pages 13-19
S.E. Hoeks, W.J.M. Scholte op Reimer, H. van Urk, P.J.G. Jörning, E. Boersma, M.L. Simoons, J.J. Bax and D. Poldermans
Links: Abstract | HTML | PDF (170K)
- Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion
Transfusion 2002 Jul;42(7):812-8).
Carson JL, Noveck H, Berlin JA, Gould SA
Links: Abstract
- Current status of transfusion triggers for red blood cell concentrates
Transfusion and Apheresis Science, Volume 31, Issue 1, August 2004, Pages 55-66.
Hardy JF
Links: Abstract | Purchase PDF (340K)
- A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. NEJM 1999;(340:409-17).
Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E.
Links: Abstract | HTML | PDF (175K)
- Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
Transfusion, Vol. 46, No. 12. (December 2006), pp. 2192-2206.
Carson JL, Terrin ML, Magaziner J, Chaitman BR, Apple FS, Heck DA, Sanders D; FOCUS Investigators
Links: Abstract | HTML | PDF (125K)
- Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells
Transfusion 1999;39(10):1089-96.
Innerhofer, P.; Luz, G.; Spötl, L.; Hobisch-Hagen, P.; Schobersberger, W.; Fischer, M.; Nussbaumer, W.; Lochs, A.; Irschick, E.
Links: Abstract
- Infectious and immunologic consequences of blood transfusion
Critical Care 2004:8:S18.
Dellinger EP, Anaya DA.
Links: Abstract | HTML | PDF (61K)
- Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?
Critical Care Medicine. 32(2):364-371, February 2004.
Walsh, Timothy S. MRCP, FRCA, MD; McArdle, Fiona BSc, MSc, RGN; McLellan, Stuart A. MRCP, FRCA; Maciver, Caroline BSc, RGN; Maginnis, Michael FIMLS; Prescott, Robin J.; McClelland, D. Brian FRCP, MD
Links: Abstract | HTML | PDF (374K)
- Perioperative blood transfusions for the recurrence of colorectal cancer
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005033.
Amato A, Pescatori M
Links: Abstract | PDF (496K)
- Colorectal surgical specimen lymph node harvest: improvement of lymph node yield with a pathology assistant
J Gastrointest Surg. 2009 Aug;13(8):1459-63.
Reese, Jeffery A.; Hall, Christopher; Bowles, Kelly; Moesinger, Robert C.
Links: Abstract | PDF (172K)
- The Evolving Multimodal Management Plan for Postoperative Ileus
Medscape CME
John B. Leslie, MD, MBA; Robert MacLaren, PharmD, BSc (Pharm), FCCM, FCCP; Theodore J. Saclarides, MD
Links: HTML | PDF (456K)
|
